Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM.

BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540.

PMID:
24215488
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.

Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K.

BMC Cancer. 2012 Aug 1;12:333.

PMID:
22853000
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.

Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK.

Lung Cancer. 2007 Sep;57(3):373-80. Epub 2007 May 21.

PMID:
17513004
[PubMed - indexed for MEDLINE]
4.

Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.

Sun BS, Li Y, Zhang ZF, You J, Wang CL.

Ann Thorac Surg. 2013 Dec;96(6):1943-51. doi: 10.1016/j.athoracsur.2013.07.089. Epub 2013 Oct 3.

PMID:
24094519
[PubMed - indexed for MEDLINE]
5.

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

Ishikawa M, Miyahara R, Sonobe M, Horiuchi M, Mennju T, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Huang CL, Date H.

Lung Cancer. 2012 Jun;76(3):431-8. doi: 10.1016/j.lungcan.2011.12.004. Epub 2012 Jan 10.

PMID:
22236865
[PubMed - indexed for MEDLINE]
6.

A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.

Ostheimer C, Bache M, Güttler A, Kotzsch M, Vordermark D.

Strahlenther Onkol. 2014 Mar;190(3):276-82. doi: 10.1007/s00066-013-0484-1. Epub 2013 Dec 11.

PMID:
24322994
[PubMed - indexed for MEDLINE]
7.

Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.

Jin Y, Tong DY, Chen JN, Feng ZY, Yang JY, Shao CK, Li JP.

PLoS One. 2012;7(10):e48575. doi: 10.1371/journal.pone.0048575. Epub 2012 Oct 31.

PMID:
23119061
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.

Blasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS.

J Clin Oncol. 2010 Feb 20;28(6):936-41. doi: 10.1200/JCO.2009.25.5711. Epub 2010 Jan 19.

PMID:
20085934
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.

Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11.

PMID:
18620780
[PubMed - indexed for MEDLINE]
10.

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.

Chen Y, Liu H, Wu W, Li Y, Li J.

J Exp Clin Cancer Res. 2013 Jul 24;32:45. doi: 10.1186/1756-9966-32-45.

PMID:
23883434
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[The expression of galectin-3 and osteopontin in occult metastasis of non-small cell lung cancer].

Liang Y, Li H, Hou SC, Hu B, Miao JB, Li T, You B, Yu LX, Wang L, Chen QR, Chen X.

Zhonghua Wai Ke Za Zhi. 2009 Jul 15;47(14):1061-3. Chinese.

PMID:
19781269
[PubMed - indexed for MEDLINE]
12.

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X.

Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Epub .

PMID:
19376608
[PubMed - indexed for MEDLINE]
13.

[Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].

Hu Z, Xiao T, Lin DM, Guo SP, Zhang ZQ, Di XB, Cheng SJ, Gao YN.

Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):591-5. Chinese.

PMID:
18210878
[PubMed - indexed for MEDLINE]
14.

Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.

Takenaka M, Hanagiri T, Shinohara S, Yasuda M, Chikaishi Y, Oka S, Shimokawa H, Nagata Y, Nakagawa M, Uramoto H, So T, Yamada S, Tanaka F.

Clin Lung Cancer. 2013 May;14(3):288-94. doi: 10.1016/j.cllc.2012.09.005. Epub 2012 Nov 1.

PMID:
23122494
[PubMed - indexed for MEDLINE]
15.

[Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].

Chen XL, Wang LC, Zhang WG, Chen XY, Sun ZM.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jul;28(7):1254-8. Chinese.

PMID:
18676277
[PubMed - indexed for MEDLINE]
Free Article
16.

Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer.

Schneider S, Yochim J, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Hölscher AH, Danenberg PV.

Clin Cancer Res. 2004 Mar 1;10(5):1588-96.

PMID:
15014008
[PubMed - indexed for MEDLINE]
Free Article
17.

Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer.

Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.

Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14.

PMID:
23319821
[PubMed - indexed for MEDLINE]
Free Article
18.

[Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].

Qi RX, Xu XY.

Zhonghua Zhong Liu Za Zhi. 2007 Sep;29(9):681-4. Chinese.

PMID:
18246798
[PubMed - indexed for MEDLINE]
19.

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer.

Boldrini L, Donati V, Dell'Omodarme M, Prati MC, Faviana P, Camacci T, Lucchi M, Mussi A, Santoro M, Basolo F, Fontanini G.

Br J Cancer. 2005 Aug 22;93(4):453-7.

PMID:
16091764
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.

Qiu ZX, Wang L, Han J, Liu D, Huang W, Altaf K, Qiu XS, Javed MA, Zheng J, Chen BJ, Li WM.

Cancer Sci. 2012 Oct;103(10):1774-9. doi: 10.1111/j.1349-7006.2012.02375.x. Epub 2012 Aug 8.

PMID:
22738312
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk